BASIS OF PRESENTATION, SIGNIFICANT CONCENTRATION AND RISKS (Narrative) (Details) (USD $)	3 Months Ended		9 Months Ended
	Sep. 30, 2013	Sep. 30, 2012	Sep. 30, 2013	Sep. 30, 2012	Dec. 31, 2012
Total cash at banks and deposits including insured amount	$ 162,673,942		$ 162,673,942		$ 132,201,606
Cash, Insured Amount	$ 523,559		$ 523,559		$ 76,101
Customers that individually comprised 10% or more of the total sales	0	0	0	0
Suppliers that comprised 10% or more of the total purchases	0	0	0	0
Customers represented 10% or more of trade receivables	0		0		0
Suppliers that represented more than 10% of accounts payables	1		1		2
Human Albumin [Member]
Major product sales percentage	49.70%	43.30%	43.30%	45.30%
Human Immunoglobulin For Intravenous Injection [Member]
Major product sales percentage	32.30%	44.10%	39.80%	39.70%